Sun Woo Hong

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignee: Olix Pharmaceuticals, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sun Woo Hong. Retrieved from https://idiyas.com/inventor/sun-woo-hong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 39(Granted Patents)

Location History:

Suwon-si, KR (2018)
Seoul, KR (2018 - 2020)
Gyeonggi-do, KR (2020 - 2021)
Suwon-si Gyeonggi-do, KR (2021)

Company Filing History:

13 out of 16

Olix Pharmaceuticals, Inc.

patents

Years Active: 2018-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12686867 - RNAi AGENT TARGETING MYD88 AND USE THEREOF (2026-07-21),

2. 11118184 - Asymmetric siRNA for inhibiting expression of male pattern hair loss target gene (2021-09-14),

3. 10947541 - Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1 (2021-03-16),

4. 10883105 - RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor (2021-01-05),

5. 10829761 - Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor (2020-11-10),

6. 10590423 - Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3 (2020-03-17),

7. 10519449 - Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB (2019-12-31),

8. 10512600 - RNA complexes that inhibit melanin production (2019-12-24),

9. 10358648 - Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1 (2019-07-23),

10. 10301628 - Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor (2019-05-28),

11. 10125362 - RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor (2018-11-13),

12. 10064801 - RNA complexes that inhibit melanin production (2018-09-04),

13. 10059949 - Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3 (2018-08-28),

Title: Sun Woo Hong - Innovative Inventor from Seoul, KR

Introduction: Sun Woo Hong is a visionary inventor hailing from Seoul, South Korea, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sun Woo Hong holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Sun Woo Hong has worked with leading research institutions and tech companies, spearheading projects that have revolutionized various industries. His commitment to pushing the boundaries of technology has earned him recognition globally.

Collaborations: Sun Woo Hong has collaborated with top universities and multinational corporations to bring his inventions to life. His ability to work in multidisciplinary teams has led to the development of cutting-edge solutions that have had a significant impact on society.

Conclusion: Sun Woo Hong's passion for innovation and his relentless pursuit of excellence make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.